Related Experiment Videos

Post-heparin hepatic and lipoprotein lipase activities in nephrotic syndrome

Australian and New Zealand Journal of Medicine
|December 1, 1984
PubMed

Insights

Nephrotic syndrome significantly reduces lipoprotein lipase activity, impacting lipid metabolism. This study explores the role of lipase enzymes in nephrotic hyperlipidemia.

Area of Science:

  • Biochemistry
  • Nephrology
  • Metabolic Disorders

Background:

  • Nephrotic syndrome is characterized by lipid metabolism abnormalities, including hypercholesterolemia and hypertriglyceridemia.
  • Understanding the specific enzymatic defects in lipid processing is crucial for managing nephrotic patients.

Purpose of the Study:

  • To investigate the activities of hepatic lipase (HL) and lipoprotein lipase (LPL) in patients with nephrotic syndrome.
  • To determine the relationship between LPL and HL activities and key lipid parameters in nephrotic patients.

Main Methods:

  • Assessed lipid profiles (cholesterol, triglycerides, HDL-cholesterol) in 18 nephrotic patients.
  • Measured post-heparin plasma HL and LPL activities using substrate-specific assays.
  • Evaluated the effect of nephrotic serum on LPL activity in normal subjects.

Main Results:

  • Lipoprotein lipase activity was markedly reduced in nephrotic patients, correlating inversely with triglyceride levels.
  • Hepatic lipase activity showed no significant difference from controls, with a weak inverse correlation to plasma albumin.
  • Nephrotic serum inhibited normal LPL activity, but inhibition degree did not correlate with hypertriglyceridemia severity.

Conclusions:

  • Reduced lipoprotein lipase activity is a key feature of lipid metabolism derangement in nephrotic syndrome.
  • Lipoprotein lipase dysfunction, potentially influenced by inhibitory factors in nephrotic serum, contributes to hypertriglyceridemia.
  • Further research into LPL regulation in nephrotic states is warranted.

Related Concept Videos